Benign multiple sclerosis: Does it exist?

Current Neurology and Neuroscience Reports

Volumn 12, Issue 5, 2012, Pages 601-609

  Correale, Jorge ^a,b   Ysrraelit, María C ^a   Fiol, Marcela P ^a  

^a FLENI   (Argentina)

^b Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

Author keywords

Benign multiple sclerosis; Cognitive impairment; EDSS; MRI; Multiple sclerosis; Natural history ofMS; Neuropsychological assessment; Prognosis; Quality of life

Indexed keywords

ARTICLE; BENIGN MULTIPLE SCLEROSIS; COGNITIVE DEFECT; DEPRESSION; DISABILITY; DISEASE COURSE; FATIGUE; HUMAN; MORBIDITY; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PREVALENCE; SOCIAL BEHAVIOR; SYMPTOM;

COGNITION DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; QUALITY OF LIFE;

EID: 84870537565     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-012-0292-5     Document Type: Article

References (93)

1. Lublin F, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46:907-11.
2. Confavreux C, Vukusic S, Adeleine S. Early clinical predictors of progression of irreversible disability in multiple sclerosis: an amnesic process. Brain. 2003;126:770-82. (Pubitemid 36372978)
3. Confavreux C, Vukusic S, Morau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000;343:1430-8.
4. Eriksson M, Andersen O, Rummarker B. Long-term follow-up of patients with clinically isolated syndromes, relapsing remitting and secondary progressive multiple sclerosis. Mult Scler. 2003;9:260-74. (Pubitemid 36681892)
5. Rummarker B, Andersen O. Prognostic factors in multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993;116:117-34. (Pubitemid 23087038)
6. Pittock S, Mayr W, McClelland R, et al. Disability profile of MS did not change over 10 years in population-based prevalence cohort. Neurology. 2004;62:601-6. (Pubitemid 38252802)
7. Pittock S, Mayr W, McClelland R, et al. Change in MS-related disability in a population-based cohort: a 10 year follow-up study. Neurology. 2004;62:51-9. (Pubitemid 38082870)
8. Rodriguez M, Siva A, Cross S, et al. Impairment, disability, and handicap in multiple sclerosis: a population based study in Olmsted County, Minnesota. Neurology. 1994;44:28-33.
9. Weinshenker B, Bass B, Rice G. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain. 1989;112:133-46. (Pubitemid 19056478)
10. Weinshenker B, Rice G, Noseworthy J, et al. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of aoutcome. Brain. 1991;114:1045-56.
11. Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology. 2005;66:172-7. (Pubitemid 43970148)
12. Cohen JA, Rudick R. Multiple sclerosis therapeutics. 4th ed. New York: Cambridge University Press; 2011.
13. Goodin DS, Frohman EM, Garmany GP, et al. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, and the MS Council for Clinical Practice Guidelines. Neurology. 2002;58:169-78. (Pubitemid 34086933)
14. Comi G. Clinically isolated syndrome: the rationale for early treatment. Nat Clin Pract Neurol. 2008;4:234-5. (Pubitemid 351639538)
15. McAlpine D. The benign form of multiple sclerosis: results of long-term study. BMJ. 1964;2:1029-32.
16. Thomson AJ, Hutchinson M, Brazil J, et al. A clinical and laboratory study of benign multiple sclerosis. Q J Med. 1986;58:69-80. (Pubitemid 16101943)
17. Hawkins SA, McDonell GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry. 1999;67:148-52. (Pubitemid 29326942)
18. Costelloe L, Thompson A, Walsh C, et al. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J Neurol Neurosurg Psychiatry. 2008;79:1245-8.
19. Ramsarransing GSM, De Keyser J. Benign course in multiple sclerosis: a review. Acta Neurol Scand. 2006;113:359-69. This article review different aspects of BMS, providing information regarding development of new definitions, prognostic factors, neuroimaging, and patophysiology of the disease. (Pubitemid 44046321)
20. Glad S, Nyland H, Myhr KM. Benign multiple sclerosis. Acta Neurol Scand. 2006;183:55-7.
21. Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology. 2007;68:496-500.
22. Patti F, Russo P, Pappalardo A, et al. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study. J Neurol Sci. 2007;252:121-9. (Pubitemid 46055242)
23. Lauer K, Firnhaber W. Epidemiological investigations into multiple sclerosis in Southern Hesse: V. Course and prognosis. Acta Neurol Scand. 1987;76:12-7. (Pubitemid 17140835)
24. Pittock SJ, McClelland RL, Mayr WT, et al. Clinical implications of benign multiple sclerosis: a 20 year population-based follow-up study. Ann Neurol. 2004;56:303-6. (Pubitemid 39037929)
25. Benedikz J, Steffansson M, Guomundsson J, et al. The natural history of untreated multiple sclerosis in Iceland: A total based population-based 50 years prospective study. Clin Neurol Neurosurg. 2002;104:208-10. (Pubitemid 34799912)
26. Poser S, Wikstrom J, Bauer HJ. Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with standardized documentation system. J Neurol Sci. 1979;40:159-68. (Pubitemid 9098457)
27. Glad SB, Aarseth JH, Nyland H, Riise T, Myhr KM. Benign multiple sclerosis: a need for a consensus. Acta Neurol Scand. 2010;122 Suppl 190:44-50.
28. Rudge P. The value of natural history studies of multiple sclerosis. Brain. 1999;122:591-2. (Pubitemid 29158769)
29. Dawson DM. Benign multiple sclerosis: some recent ideas. Curr Neurol Neurosci Rep. 2008;8:1-4. (Pubitemid 351166409)
30. Engell T. A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand. 1989;79:428-30. (Pubitemid 19129066)
31. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-31. (Pubitemid 13158528)
32. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain. 1989;112:1419-28. (Pubitemid 20024212)
33. Fog T, Linnemann F. The course of multiple sclerosis in 73 cases with computer-designed curves. Acta Neurol Scand. 1970;47 (Suppl):3-175.
34. Patzold U, Pocklington P. Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976 to 1980. Acta Neurol Scand. 1982;65:248-66.
35. Phadke JG. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain. 1990;113:1597-628.
36. Ramsaransing G, Mauritis N, Zwanikken C, De Keyser J. Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler. 2001;7:345-7. (Pubitemid 33026261)
37. Glad SB, Nyland HI, Aarset JH, Riise T, Myhr KM. Long-term follow-up of benign multiple sclerosis in Horland County, Western Norway. Mult Scler. 2009;15:942-50.
38. Midgard R, Albrektsen G, Riise T, et al. Prognostic factors for survival in multiple sclerosis: a longitudinal population based study in More and Romsdal, Norway. J Neurol Neurosurg Psychiatry. 1995;58:417-21.
39. Kurtzke JF, Beebe GW, Nagler B, et al. Studies on the natural history of multiple sclerosis: 8. Early prognostic features of the alter course of the illness. J Chronic Dis. 1977;30:819-30. (Pubitemid 8242208)
40. Leibowitz U, Alter M. Clinical factors associated with increased disability in multiple sclerosis. Acta Neurol Scand. 1970;46:53-70.
41. McAlpine D. The benign form of multiple sclerosis: a study based on 241 cases seen in three years of onset and followed up until the tenth year or more of the disease. Brain. 1961;84:186-203.
42. Ramsaransing GSM, De Keyser J. Predictive value of clinical characteristics for "benign" multiple sclerosis. Eur J Neurol. 2007;14:885-9. (Pubitemid 47106771)
43. Sayao AL, Bueno AM, Devonshire V, et al. The psychosocial and cognitive impact of longstanding "benign" multiple sclerosis. Mult Scler J. 2011;17:1375-83.
44. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability sattus scale (EDSS). Neurology. 1983;33:1444-52. (Pubitemid 14237132)
45. Correale J, Peirano I, Romano L. Benign multiple sclerosis: a new definition of this entity is needed. Mult Scler J. 2012;18:210-8.
46. Chiavalloti N, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Nerol. 2008;7:1139-51.
47. Amato MP, Zipoli V, Goretti B, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol. 2006;253:1054-9. A seminal article describing cognitive impairment in BMS patients, as well as worsening of fatigue and depression, with negative impact on work and social activities. The article suggests that current BMS definition may overestimate incidence of the pathology. (Pubitemid 44441131)
48. Portaccio E, Stromillo ML, Goretti B, et al. Neuropsychological and MRI measures predict-short term evolution in benign multiple sclerosis. Neurology. 2009;73:498-503.
49. Trisolini M, Honeycutt A, Wiener J, Lesesne S. Global economy impact of multiple sclerosis. http://www.msif.org/document.rm? id0651. Accessed March 2012.
50. Glad SB, Nyland H, Aarset JH, et al. How long can you keep working with benign multiple sclerosis? J Neurol Neurosurg Psychiatry. 2011;82:78-82.
51. Rao SM, Leo GJ, Ellington L, et al. Cognitive dysfunction in multiple sclerosis: II. Impact on employment and social functioning. Neurology. 1991;41:692-6.
52. Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler. 2005;11:602-9. (Pubitemid 41387707)
53. Rovaris M, Barkhof F, Calabrese M, et al. MRI features of benign multiple sclerosis: towards a definition of this disease subtype. Neurology. 2009;72:1693-701. This article, based on MRI studies, reviewed potential mechanisms to explain the BMS course. The authors suggested, as possible explanations for their findings, (1) paucity of tissue damage within and outside lesions, (2) sparing of clinically eloquent regions, and (3) presence of effective compensatory mechanisms..
54. Koopmans RA, Li DK, Grochowski E, et al. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol. 1989;25:74-81. (Pubitemid 19032846)
55. Filippi M, Capra R, Campi A, et al. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry. 1996;60:526-30. (Pubitemid 26147894)
56. Thompson AJ, Kermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ. 1990;300:631-4. (Pubitemid 20107324)
57. Strasser-Fuchs S, Enzinger C, Ropele S, et al. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox? Mult Scler. 2008;14:205-11. (Pubitemid 351639629)
58. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008;131:808-17. (Pubitemid 351294716)
59. Rocca MA, Colombo B, Falini A, et al. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol. 2005;4:618-26. (Pubitemid 41317296)
60. Rocca MA, Ceccarelli A, Rodegher M, et al. Preserved brain adaptive properties in patients with benign multiple sclerosis. Neurology. 2010;74:142-9.
61. Filippi M, Iannucci G, Tortorella C, et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology. 1999;52:588-94. (Pubitemid 29075609)
62. DeStefano N, Battaglini M, Stromillo ML, et al. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain. 2006;129:2008-16. (Pubitemid 44289066)
63. Amato MP, Portaccio E, Stromillo ML, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology. 2008;71:632-8.
64. Benedetti B, Rovaris M, Rocca MA, et al. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis. Mult Scler. 2009;15:789-94.
65. Gauthier SA, Berger AM, Liptak Z, et al. Rates of brain atrophy in benign vs early multiple sclerosis. Arch Neurol. 2009;66:234-7.
66. Brass SD, Narayanan S, Antel JP, et al. Axonal damage in multiple sclerosis patients with high versus low disability. Can J Neurol Sci. 2004;31:225-8. (Pubitemid 38724816)
67. Benedetti B, Rovaris M, Rocca M, et al. Neuroaxonal brain viability does not differ between benign and relapsing-remitting MS patients. Neurol Sci. 2008;29(Suppl):S196.
68. Mesaros S, Rovaris M, Pagani E, et al. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol. 2008;65:1223-30. This article proposed cerebellar gray matter atrophy as a major determinant of irreversible locomotor disability in MS, with absence of this finding in BMS possibly explaining the favorable disease course.
69. Ceccareli A, Filippi M, Neema M, et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult Scler. 2009;15:678-86.
70. Calabrese M, Filippi M, Rovaris M, et al. Evidence of relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler. 2009;15:36-41.
71. Feinstein A. The clinical neuropsychiatry of multiple sclerosis. Cambridge: Cambridge University Press; 1999.
72. Lin X, Biumhardt L, Constanstinescu C. The relationship of brain and spinal cord volume to disability in clinical subtypes of multiple sclerosis: a three dimensional MRI study. Acta Neurol Scand. 2003;108:401-6. (Pubitemid 37464119)
73. Lycklama à Nijeholt GJ, van Walderveen MA, Castelijns JA, et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain. 1998;121:687-97. (Pubitemid 28162129)
74. Benedetti B, Rocca MA, Rovaris M, et al. A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients. J Neurol Neurosurg Psychiatry. 2010;81:26-30.
75. Filippi M, Campi A, Colombo B, et al. Spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol. 1996;243:502-5. (Pubitemid 26239702)
76. Giorgio A, Portaccio E, Stromillo ML, et al. Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis. Mult Scler. 2010;16:1326-34.
77. Rocca MA, Valsasina P, Cecarelli A, et al. Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp. 2009;30:276-90.
78. Penner IK, Rausch M, Kappos L, et al. Analysis of impairment related functional architecture in MS patients during performance of different attention task. J Neurol. 2003;250:461-72. (Pubitemid 36459754)
79. Pollman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revision of the McDonald criteria. Ann Neurol. 2011;69:292-302.
80. Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007;6:677-86. (Pubitemid 47064439)
81. Guttman CR. Simplified MRI prediction of clinically definite multiple sclerosis: a stepping stone towards treatment criteria. Nat Clin Pract Neurol. 2008;4:136-7.
82. McAlpine D. The benign form of multiple sclerosis: a study based on 241 cases seen within three years of onset and followed up until the tenth year of the disease. Brain. 1961;84:186-203.
83. Riser M, Géraud J, Rascol A, et al. L'evolution de la sclérose en palques étude de 203 observations suivies au-delá de 10 ans. Rev Neurol Paris. 1971;124:479-86.
84. Shepered DI. Clinical features of multiple sclerosis in north-east Scotland. Acta Neurol Scand. 1979;60:218-30.
85. Amato MP, Ponziani G, Bartolozzi ML, Siracusa G. A prospective study on the natural history of multiple sclerosis clues to the conduct and interpretation of clinical trials. J Neurol Sci. 1999;168:96-106. (Pubitemid 29467426)
86. Poser S, Raun NE, Poser W. Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand. 1982;66:355-62. (Pubitemid 12061611)
87. Hutchinson M. Disability due to multiple sclerosis: a communitybased study of an Irish county. Irish Med J. 1986;79:48-50.
88. McDonell GV, Hawkins SA. An epidemiologic study of multiple sclerosis in Northern Island. Neurology. 1998;50:423-8. (Pubitemid 28119783)
89. Cabre P, Heinzlef O, Merle H, et al. MS and neuromyelitis óptica in Martinique (French and West Indies). Neurology. 2011;56:507-14.
90. Krisztina B, Rajda C, Füvesi J, et al. The prevalence of MS distribution of clinical forms of the disease and functional status of patients in Csóngrad County, Hungary. Eur Neurol. 2011;46:206-9.
91. Perini P, Tagliaferri C, Belloni M, et al. The HLA-DR13 haplotype associated with "benign" multiple sclerosis in northeast Italy. Neurology. 2001;57:158-9. (Pubitemid 32634873)
92. Kalanie H, Ghaagozli K, Kalanie AR. Multiple sclerosis: report of 200 cases from Iran. Mult Scler. 2003;9:36-8. (Pubitemid 36253694)
93. Hirst C, Ingram G, Swingler, et al. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis. J Neurol Neurosurg Psychiatry. 2008;79:1137-43.